VIRONOSTIKA HIV-1 MICROELISA SYSTEM
Report
- Report Number
- 3002769706-2006-00005
- Event Type
- Malfunction
- Date Received
- December 21, 2006
- Date of Event
- November 2, 2006
- Report Date
- December 15, 2006
- Manufacturer
- BIOMERIEUX, INC.
- Product Code
- MTP
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- UNKNOWN
Narratives
BIOMERIEUX INC. IS INITIATING A VOLUNTARY RECALL OF THE VIRONOSTIKA HIV- MICROELISA SYSTEM (PRODUCT # 259605, 259717) FOR THE LOT NOTED ABOVE. THIS RECALL IS BEING CONDUCTED AS A RESULT OF AN INTERNAL QUALITY INVESTIGATION IN WHICH WE WERE ABLE TO CONFIRM ONE CUSTOMER COMPLAINT OF NO REACTIVITY ON A SINGLE COATED PLATE FROM THIS LOT. WE BELIEVE THAT THIS COMPLAINT MAY BE AN ISOLATED INCIDENT, HOWEVER, WE CANNOT DETERMINE THIS WITH CERTAINTY, THEREFORE WE ARE RECALLING THIS LOT. UNDER MOST CONDITIONS OF USE, A NON-REACTIVE STRIP WOULD BE DETECTED BY THE KIT'S POSITIVE CONTROL. HOWEVER, THE POTENTIAL FOR FALSE NEGATIVE RESULTS DOES EXIST IF A CUSTOMER COMBINES STRIP WELLS FROM A REACTIVE PLATE WITH STRIP WELLS FROM AN AFFECTED NON-REACTIVE PLATE. THIS COMBINATION WOULD RESULT IN A VALID RUN IF THE KIT CONTROLS WERE TESTED ON THE REACTIVE STRIP. TESTING OF ADDITIONAL KITS FROM SAME CUSTOMER AND RETAINS DID NOT DUPLICATE PROBLEM. THE QUALITY ASSURANCE DEPARTMENT AT THE BIOMERIEUX DURHAM HAS ISSUED A CAPA # 1359 TO CONTINUE THE INVESTIGATION TO CLEARLY IDENTIFY ROOT CAUSE AND IMPLEMENT PREVENTIVE ACTION. UPON DETERMINATION OF A ROOT CAUSE, PREVENTIVE ACTION WILL BE IMPLEMENTED WITHIN THE APPLICABLE IDENTIFIED PROCESSES PER THE CAPA PROCESS.
THE INITIAL COMPLAINT WAS THAT, THE CUSTOMER IS SEEING NO REACTIVITY ON 1 OF 2 PLATES IN 192T KIT LOT #160354. QC IMMUNODIAGNOSTICS WAS ABLE TO CONFIRM THIS CUSTOMER COMPLAINT OF NO REACTIVITY AND DETERMINE THE DEFECT TO BE ISOLATED TO THE COATED PLATES STRIPS. FOLLOWING A COMPREHENSIVE DATA REVIEW OF CUSTOMER AND QC IMMUNODIAGNOSTICS GENERATED DATA, IT WAS DETERMINED THAT THE CUSTOMER PLATE WAS NON-REACTIVE. WITHIN TYPICAL LAB PRACTICES, THIS SHOULD HAVE BEEN IDENTIFIED THROUGH THE USE OF THE POSITIVE CONTROL. IT SHOULD ALSO BE NOTED THAT PATIENT RESULTS WERE NOT REPORTED FROM THIS ISOLATED INCIDENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | VIRONOSTIKA HIV-1 MICROELISA SYSTEM | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | MTP | BIOMERIEUX, INC. | 259605/25717 | 160354 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | YR | Required Intervention |